Sustainability: Unlocking The Hidden Value Outside Of ESG Metrics
Collecting this data requires a comprehensive IoT platform—but is that its only role? Or can it offer even more?
The Manila Times3h
Alvotech and Dr. Reddy's Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
"The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
Alvotech S.A.: Alvotech and Dr. Reddy's Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia and Xgeva
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's") and Alvotech (NASDAQ: ALVO), a global biotech ...
There’s Now a Jewish-Advocacy ETF. Here’s What One Financial Advisor Thinks.
The JLens 500 Jewish Advocacy U.S. ETF launched late last month and has already amassed more than $100 million in assets.
Manila Standard15h
The Cost of Carbon: Can Taxes and ESG Save the Planet?
Human activity has made normal climate change abnormal. In our quest to expand and modernize our living conditions, we ...